Important information - the value of investments and the income from them, can go down as well as up, so you may get back less than you invest.
Five of the 10 best-selling ETFs on the Fidelity platform last month were global tracker funds, which is much as we have come to expect.
More noteworthy perhaps were some of our customers’ other choices, such as two ETFs that reduce or eliminate exposure to America’s most valuable and prominent companies and one that focuses solely on AI infrastructure. And, while one emerging markets ETF made the list, UK-focused funds were conspicuous by their absence.
Read on to discover July’s top 10 best-selling ETFs, or click below to explore the month’s best-selling investment trusts, ISA and SIPP funds.
- Read: Top 10 best-selling ISA and SIPP funds in July
- Read: Top 10 best-selling investment trusts in July
‘Plain vanilla’ global trackers took the first two places on the list of 10 best-selling exchange-traded funds among Fidelity customers last month. They were the Vanguard FTSE All-World and the Invesco FTSE All-World ETFs. Both track the FTSE All-World index, which includes companies from around the world, so these ETFs offer investors very broad exposure to global stock markets.
Next came the first fund to take a more nuanced approach. The iShares MSCI World Ex USA ETF explicitly avoids American stocks and instead invests across other developed markets.
This type of fund may appeal to several types of investor.They include those who already have exposure to Wall Street, perhaps via direct holdings or actively managed funds; those who want to control their US allocation separately rather than accept the weighting provided by a global tracker; and those who want to avoid the US stock market because they fear it is overvalued or that the AI investment boom will prove unsustainable.
- Looking for personalised financial advice? Our advisory service can help you plan for your next step
In fourth place was a fund for the opposite kind of investor, those who want straightforward exposure to the largest American companies. This ETF, the iShares Core S&P 500, offers exactly that.
The Amundi Smart Overnight Return ETF, which is akin to a cash fund, came next in the list. Although it yields 4.1% at present, income is reinvested. Yields are variable and not guaranteed.
Another straightforward global equity fund, the Legal & General Global Equity ETF, occupied sixth place. This ETF tracks the Solactive Core Developed Markets Large & Mid Cap index.
In seventh place was the emerging markets tracker we alluded to in the opening paragraph, namely the iShares Core MSCI Emerging Markets IMI ETF.
IMI stands for investable markets index, a term explained in our article Top 10 best-selling ETFs in January. The ETF is a member of Fidelity’s Select 50 list of recommended funds, compiled by Fundhouse, an independent research firm. Fundhouse says of the ETF: ‘BlackRock, which runs iShares, has good experience in index tracking and this fund is well priced.’ The ETF’s ‘ongoing charge’ is 0.18% a year.
The iShares AI Infrastructure ETF was in eighth place. While some investors seem to want to limit exposure to the AI theme, to judge by the ex USA fund in third place and the ‘equal weight’ ETF we’ll come to in a moment, others are still keen to buy a fund that offers nothing else.
We should not assume, however, that investors who buy this fund are putting all their money into AI; prudent savers may want some AI stocks as part of a well diversified portfolio and see a fund such as this as a convenient and low-cost way to get such exposure.
Ninth place in the table was taken by the Vanguard FTSE Developed World ETF, another global tracker. As its name indicates, the fund excludes emerging markets. (Less obviously, so too do funds that track what is perhaps the most popular global index, the MSCI World. By contrast, the MSCI ACWI, or All Country World Index, includes emerging markets.)
Finally in the 10th spot in the best-sellers’ table came the Invesco MSCI World Equal Weight ETF.
The key point about this fund is that every constituent is given the same weight. This contrasts with most other trackers, which have larger positions in the more valuable companies and are referred to as ‘capitalisation weighted’.
The practical effect is that this ETF has far less exposure to giant companies such as the ‘Magnificent 7’ and less exposure to American stocks generally (42.2% against 72% for the capitalisation-weighted MSCI World index). It can be seen as a more balanced way to get global stock market exposure.
Top 10 best-selling ETFs on Fidelity Personal Investing in July 2026
- Vanguard FTSE All-World
- Invesco FTSE All-World
- iShares MSCI World Ex USA
- iShares Core S&P 500
- Amundi Smart Overnight Return
- Legal & General Global Equity
- iShares Core MSCI Emerging Markets Investable Market Index
- iShares AI Infrastructure
- Vanguard FTSE Developed World
- Invesco MSCI World Equal Weight
Source: Fidelity International. Total net ETF sales from ISA, SIPP and Investment Accounts in July 2026 for Personal Investors only.
Got a burning question you want to ask? Why not drop us a line. Click here to ask your question.
Important information - investors should note that the views expressed may no longer be current and may have already been acted upon. Before investing, please read the relevant key information document which contains important information about each investment trust. There is no guarantee that the investment objective of any Index Tracking Sub-Fund will be achieved. The performance of the sub-fund may not match the performance of the index it tracks due to factors including, but not limited to, the investment strategy used, fees and expenses and taxes. Overseas investments will be affected by movements in currency exchange rates. Select 50 is not a personal recommendation to buy or sell a fund. Eligibility to invest in an ISA and tax treatment depends on personal circumstances and all tax rules may change in the future. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice.
Share this article
Latest articles
Should you spend all your money in retirement?
Marianna Hunt puts the controversial 'Die With Zero' philosophy to the test
Top 10 best-selling investment trusts in July
The most popular trusts with our investors last month